Primary systemic carnitine deficiency: a Turkish case with a novel homozygous SLC22A5 mutation and 14 years follow-up

J Pediatr Endocrinol Metab. 2015 Sep;28(9-10):1179-81. doi: 10.1515/jpem-2014-0528.

Abstract

Systemic primary carnitine deficiency is an autosomal recessive disorder caused by the deficiency of carnitine transporter. Main features are cardiomyopathy, myopathy and hypoglycemic encephalopathy. We report a Turkish case with a novel SLC22A5 gene mutation presented with a pure cardiac phenotype. During the 14-year follow-up study, cardiac functions were remained within a normal range with oral L-carnitine supplementation.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Cardiomyopathies / drug therapy
  • Cardiomyopathies / genetics*
  • Carnitine / deficiency*
  • Carnitine / genetics
  • Carnitine / therapeutic use*
  • Child
  • Child, Preschool
  • Hormone Replacement Therapy
  • Humans
  • Hyperammonemia / drug therapy
  • Hyperammonemia / genetics*
  • Male
  • Muscular Diseases / drug therapy
  • Muscular Diseases / genetics*
  • Mutation*
  • Organic Cation Transport Proteins / genetics*
  • Solute Carrier Family 22 Member 5
  • Turkey

Substances

  • Organic Cation Transport Proteins
  • SLC22A5 protein, human
  • Solute Carrier Family 22 Member 5
  • Carnitine

Supplementary concepts

  • Systemic carnitine deficiency